Lv7
4780 积分 2021-05-19 加入
Adjuvant oxaliplatin with S-1 (SOX) versus S-1 for stage II–III gastric cancer (CAPITAL): A randomized, open-label, phase 3 trial
6天前
已完结
Advances in Systemic Treatment of Breast Cancer
8天前
已完结
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
9天前
已完结
Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study
29天前
已完结
Preoperative Chemoradiotherapy for Resectable Gastric Cancer
29天前
已完结
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
29天前
已完结
An open‐label phase II study: The efficiency and safety of anlotinib + eribulin in patients with HER2 ‐negative metastatic breast cancer
1个月前
已完结
Taxane-Associated Acute Pain Syndrome: a Review of its Features and Management
1个月前
已完结
The Paclitaxel Acute Pain Syndrome: Sensitization of Nociceptors as the Putative Mechanism
1个月前
已完结
Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer—a systematic review
1个月前
已完结
皖公网安备34019202002308
